不同转移潜能人肝癌细胞株趋化因子受体谱差异表达

Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials

目的对比观察不同转移潜能人肝癌细胞株趋化因子受体谱差异性表达。方法Pre- mier软件设计18对趋化因子受体引物,RT-PCR分析SMMC-7721、MHCC97-L、MHCC97-H和HCCLM6细胞侵袭转移潜能逐渐增强的人肝癌细胞株趋化因子受体谱。结果4组不同转移潜能细胞株趋化因子受体表达谱存在明显差异（P＜0．01）,其中CCR10、CXCR4、CXCR6表达随转移潜能增加逐渐降低。HCCLM6表达谱中CCR3、CCR4、CCR10、CCR12及XCR1比SMMC-7721表达明显降低甚至缺失（P＜0．01）,而CXCR1（P=0．006）、CXCR5（P=0．003）表达高于低转移潜能组SMMC-7721。MHCC97-H和MHCC97-L比较,除CXCR2、CXCR6、XCR1外差异均有统计学意义,其中CCR1（P=0．002）、CCR2（P=0．004）、CCR5（P=0．046）表达高于MHCC97- L。CXCR4在模板减量时只能在SMMC-7721组检测到。结论高低转移潜能肝癌细胞株趋化因子受体表达在mRNA水平存在差异性表达,与肝癌细胞株差异性转移潜能相关。

Objective To compare different expression profiles of all known chemokine receptors in human hepatocellular carcinoma （HCC） cell lines with different metastasis potentials. Methods Eighteen pairs of chemokine receptor primers were designed using Premier software. Expression profiles of the 18 chemokine receptors on four HCC cell lines of lower to higher potentials of metastasis （SMMC-7721, MHCC97- L, MHCC97-H and HCCLM6） were analyzed by RT-PCR. Expression of CXCR4 was detected by RT-PCR. Results Expression profiles of chemokine receptors on four HCC cell lines with different metastatic potentials had significant differences （P 〈 0.01）, in which CCR 10, CXCR4 and CXCR6 expressions decreased gradually as the metastatic potential of the cell lines increased. The expressions of CCR3, CCR4, CCR10, CCR12 and XCR1 on HCCLM6 were significantly reduced compared with SMMC-7721 （P 〈 0.01）, whereas the expressions of CXCR1 （P = 0.006） and CXCR5 （P = 0.003） exceeded that of SMMC-7721. Except for CXCR2, CXCR6 and XCR1, most of chemokine receptors on MHCC97-H were expressed differently com- pared with MHCC97-L （P 〈 0.05）, in which expressions ofCCR1 （P = 0.002）, CCR2 （P = 0.004） and CCR5 （P = 0.046） exceeded MHCC97-L. CXCR4 was detected only on the positive controls and SMMC-7721 when the template of total RNA was reduced one-half in RT-PCR. Conclusion Chemokine receptors are expressed very differently at mRNA level on HCC cell lines with different metastatic potentials. The different profiles of chemokine receptors in tumor microenvironment and the function of CXCR4 in HCC should be further studied. Our findings have important implications in understanding the relationship between chemokine receptors and the metastatic potential of HCC.